The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders

Pribytkov A.A.

doi:https://doi.org/10.17116/jnevro20161165152-56

Pribytkov A.A.

Penza Institute for Postgraduate Fraining, Penza, Russia

The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders

Authors:

Pribytkov A.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5): 52‑56

DOI: 10.17116/jnevro20161165152-56

Read: 1409 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Pribytkov AA. The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5):52‑56. (In Russ.)
https://doi.org/10.17116/jnevro20161165152-56

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

Stress and sleep: Neurobiological aspects and modern options of insomnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21

Early diagnosis and effective therapy of diabetic polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):62-68

Vertebroplasty for pathological vertebral fracture with osteoporosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):67-76

Results of the All-Russian consensus conference on complications in bariatric surgery. Endoscopic Surgery. 2025;(1):15-24

Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coronary intervention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200

Influence of griseofulvin on intestinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):185-190

Chronic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medicine. 2025;(2):5-16

Portopulmonary hypertension. Journal of Respiratory Medicine. 2025;(2):39-44

Diagnosis and treatment of ovarian cancer in pregnancy. Russian Bulletin of Obstetrician-Gynecologist. 2025;(3):27-33

Abstract:

Objective. To assess the efficacy of monotherapy with sertraline or its combinations with phenazepam or thioridazine in patients with somatoform disorders. Material and methods. The open study included 65 patients divided into three groups according to the drug used. Clinical condition of the patients was evaluated with CGI and Hamilton scale. The Screening for Somatoform Symptoms 7 was administered as well. Results and conclusion. During the treatment, a significant decrease in the severity of somatoform disorders was observed in all groups. The more rapid development of therapeutic effect, including the reduction in anxiety symptoms in the sertraline + phenazepam group, was found. There were no significant differences between the sertraline group and the sertraline+ thioridazine group. The differences were identified only during three weeks of treatment while there were no between-group differences in the 4th week. In accordance to these results, the duration of adjunctive therapy with benzodiazepines should be limited in time.

Keywords:

somatoform disorders

treatment

sertraline

bromdihydrochlorphenylbenzodiazepine (phenazepam)

thioridazine

Authors:

Pribytkov A.A.

Penza Institute for Postgraduate Fraining, Penza, Russia

Close metadata

References:

Andrjushhenko AV. Rasprostranennost' i struktura psihicheskih rasstrojstv v obshhej medicine. Psihicheskie rasstrojstva v obshhej medicine. 2011;1:14-27. (In Russ.).
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Swensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen H-C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655-679. doi: 10.1016/j.euroneuro.2011.07.018.
Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;11:CD010628. doi: 10.1002/14651858.CD010628.pub2.
Decoutere L, van den Eede F, Moorkens G, Sabbe BG. Antipsychotic agents in the treatment of somatoform disorders; a review. Tijdschr Psychiatr. 2011;53:163-173.
Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881-888. doi: 10.1097/PSY.0b013e31815b00c4.
van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;11. doi: 10.1002/14651858.CD011142.
Fink P, Burton C, de Bie J, Söllner W, Fritzsche K. Current state of management and organization of care. Eds. Creed F., Henningsen P., Fink P. In: Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambridge: Cambridge University Press. 2011;97-123. doi: 10.1017/CBO9780511977862.005.
Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946-955. doi: 10.1016/S0140-6736(07)60159-7.
olde Hartman TC, Lucassen PL, van de Lisdonk EH, Bor HHJ, van Weel C. Chronic functional somatic symptoms: a single syndrome? Br J Gen Pract. 2004;54:509:922-927.
Pribytkov AA, Baryl'nik JuB, Antohin EJu, Jurkova IO, Emcov KG, Deeva MA, Jakushina AM. Terapija somatoformnyh rasstrojstv: dannye issledovanij i povsednevnaja praktika. Psihiatrija i psihofarmakoterapija. 2015;3:34-38. (In Russ.).
Mundt A, Ströhle A, Heimann H, Grohmann. Pharmacoepidemiology of patients hospitalized for somatoform disorders in psychiatric hospitals and departments. Pharmacoepidemiol Drug Saf. 2010;19(7):687-693. doi: 10.1002/pds.1976.
Rief W, Hiller W. A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics. 2003;44:492-498. doi: 10.1176/appi.psy.44.6.492.